SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Get Free Report) shares saw unusually-strong trading volume on Friday . 176,404 shares changed hands during trading, an increase of 99% from the previous session’s volume of 88,849 shares.The stock last traded at $71.43 and had previously closed at $72.41.
SPDR S&P Pharmaceuticals ETF Price Performance
The company has a fifty day moving average price of $68.68 and a two-hundred day moving average price of $60.98. The firm has a market cap of $511.20 million, a price-to-earnings ratio of 14.28 and a beta of 0.58.
Hedge Funds Weigh In On SPDR S&P Pharmaceuticals ETF
Several hedge funds have recently made changes to their positions in XPH. Goldman Sachs Group Inc. raised its holdings in shares of SPDR S&P Pharmaceuticals ETF by 96.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 119,929 shares of the company’s stock worth $5,253,000 after purchasing an additional 59,007 shares in the last quarter. Jane Street Group LLC acquired a new position in SPDR S&P Pharmaceuticals ETF in the first quarter worth approximately $308,000. JPMorgan Chase & Co. increased its holdings in shares of SPDR S&P Pharmaceuticals ETF by 9.4% in the second quarter. JPMorgan Chase & Co. now owns 57,258 shares of the company’s stock valued at $2,324,000 after buying an additional 4,918 shares in the last quarter. EP Wealth Advisors LLC acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF during the 2nd quarter valued at $278,000. Finally, Corient Private Wealth LLC acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF during the 2nd quarter valued at $294,000.
SPDR S&P Pharmaceuticals ETF Company Profile
SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Articles
- Five stocks we like better than SPDR S&P Pharmaceuticals ETF
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
- BWX Technologies’ Army Reactor Win Could Redraw Its Nuclear Growth Story
Receive News & Ratings for SPDR S&P Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
